Product Code: A04162
Transcatheter mitral valve repair and replacement is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. In case of mitral valve misfunctioning, an individual can experience symptom such as fatigue and shortness of breath. Mitral valve diseases occurs when mitral valve does not pump enough blood out of the left ventricular chamber to supply the body with oxygen-filled blood. Mitral valve disorders are severe, if untreated, they may lead to heart failure and irregular heartbeats called arrhythmias.
The major factors that drive the growth of the global transcatheter mitral valve repair and replacement market include increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves. However, implementation of stringent regulations by governing bodies for the approval of novel mitral valve stents, high cost of mitral valve surgeries, and risks associated with this procedure restrain the market growth. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.
The global transcatheter mitral valve repair and replacement market is segmented into product, indication, and region. According to product, the market is divided into mechanical valves and bioprosthetic tissue (biological) valves. By indication, it is categorized into mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include: LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transcatheter mitral valve repair & replacement market analysis from 2020 to 2030 to identify the prevailing transcatheter mitral valve repair & replacement market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the transcatheter mitral valve repair & replacement market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global transcatheter mitral valve repair & replacement market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Indications
- Mitral Valve Stenosis
- Mitral Valve Prolapse
- Mitral Valve Regurgitation
By BY PRODUCT
- Mechanical Valves
- Bioprosthetic Tissue (Biological) Valves
By Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- ABBOTT LABORATORIES
- BIOTRONIK SE & CO. KG
- COLIBRI HEART VALVE, LLC.
- EDWARDS LIFE SCIENCE CORPORATION
- HLT, INC.
- LIVANOVA PLC
- MEDTRONIC PLC
- NEOVASC INC.
- NEOCHORD INC.
- CORAMAZE TECHNOLOGIES GMBH.
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Mechanical Valves
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Bioprosthetic Tissue (Biological) Valves
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
CHAPTER 5: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Mitral Valve Stenosis
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Mitral Valve Prolapse
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Mitral Valve Regurgitation
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
CHAPTER 6: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Product
- 6.2.3 North America Market size and forecast, by Indications
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Market size and forecast, by Product
- 6.2.4.1.2 Market size and forecast, by Indications
- 6.2.4.2 Canada
- 6.2.4.2.1 Market size and forecast, by Product
- 6.2.4.2.2 Market size and forecast, by Indications
- 6.2.4.3 Mexico
- 6.2.4.3.1 Market size and forecast, by Product
- 6.2.4.3.2 Market size and forecast, by Indications
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Product
- 6.3.3 Europe Market size and forecast, by Indications
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Market size and forecast, by Product
- 6.3.4.1.2 Market size and forecast, by Indications
- 6.3.4.2 France
- 6.3.4.2.1 Market size and forecast, by Product
- 6.3.4.2.2 Market size and forecast, by Indications
- 6.3.4.3 U.K.
- 6.3.4.3.1 Market size and forecast, by Product
- 6.3.4.3.2 Market size and forecast, by Indications
- 6.3.4.4 Italy
- 6.3.4.4.1 Market size and forecast, by Product
- 6.3.4.4.2 Market size and forecast, by Indications
- 6.3.4.5 Spain
- 6.3.4.5.1 Market size and forecast, by Product
- 6.3.4.5.2 Market size and forecast, by Indications
- 6.3.4.6 Rest of Europe
- 6.3.4.6.1 Market size and forecast, by Product
- 6.3.4.6.2 Market size and forecast, by Indications
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Product
- 6.4.3 Asia-Pacific Market size and forecast, by Indications
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 Japan
- 6.4.4.1.1 Market size and forecast, by Product
- 6.4.4.1.2 Market size and forecast, by Indications
- 6.4.4.2 China
- 6.4.4.2.1 Market size and forecast, by Product
- 6.4.4.2.2 Market size and forecast, by Indications
- 6.4.4.3 India
- 6.4.4.3.1 Market size and forecast, by Product
- 6.4.4.3.2 Market size and forecast, by Indications
- 6.4.4.4 Australia
- 6.4.4.4.1 Market size and forecast, by Product
- 6.4.4.4.2 Market size and forecast, by Indications
- 6.4.4.5 South Korea
- 6.4.4.5.1 Market size and forecast, by Product
- 6.4.4.5.2 Market size and forecast, by Indications
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Market size and forecast, by Product
- 6.4.4.6.2 Market size and forecast, by Indications
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Product
- 6.5.3 LAMEA Market size and forecast, by Indications
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Brazil
- 6.5.4.1.1 Market size and forecast, by Product
- 6.5.4.1.2 Market size and forecast, by Indications
- 6.5.4.2 Saudi Arabia
- 6.5.4.2.1 Market size and forecast, by Product
- 6.5.4.2.2 Market size and forecast, by Indications
- 6.5.4.3 South Africa
- 6.5.4.3.1 Market size and forecast, by Product
- 6.5.4.3.2 Market size and forecast, by Indications
- 6.5.4.4 Rest of LAMEA
- 6.5.4.4.1 Market size and forecast, by Product
- 6.5.4.4.2 Market size and forecast, by Indications
CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
CHAPTER 8: COMPANY PROFILES
- 8.1 ABBOTT LABORATORIES
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 BIOTRONIK SE & CO. KG
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 COLIBRI HEART VALVE, LLC.
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 EDWARDS LIFE SCIENCE CORPORATION
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 HLT, INC.
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 LIVANOVA PLC
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 MEDTRONIC PLC
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 NEOVASC INC.
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 NEOCHORD INC.
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 CORAMAZE TECHNOLOGIES GMBH.
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments